ERBB2 and breast cancer: The data is still not enough to powerfully support the relationship between the oral contraceptive in breast cancer and the variable impact of oral contraceptives on different breast tissue receptors, which are the main players in breast cancer development like estrogen receptor (ER), progesterone receptor (PR), human epidermal growth factor receptor 2 (HER2) [170].